At 28 years old, Dr. Soania Mathur was building her medical practice and expecting her first child. Then she was diagnosed ...

Manufactured by AbbVie, Produodopa is a subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe ...

Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease, according to a study published online March ...

Deep brain stimulation is a game-changer for patients like Peters amid the ongoing fight for medical breakthroughs for ...

US Neurologists express enthusiasm for new ways to administer current treatments and future disease modifying therapies, according to .Exton, Pennsylvania, May 09, 2024 (GLOBE NEWSWIRE) -- Even as the ...

Among the lixisenatide and placebo groups, 100% and 97% were receiving levodopa, 45% and 41% were receiving monoamine oxidase B inhibitors, and 69% and 78% were receiving dopamine agonist, ...

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on TRVI stock, giving a Buy rating yesterday. Thomas Smith has given ...

ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) ...

Q1 2024 Earnings Call Transcript May 8, 2024 ACADIA Pharmaceuticals Inc. isn’t one of the 30 most popular stocks among hedge ...

THURSDAY, April 11, 2024 (HealthDay News) -- Subcutaneous infusion of ND0612 (a levodopa-carbidopa solution) increases on time without troublesome dyskinesia among patients with Parkinson disease ...

Net sales of Qelbree® increased 75% to $45.1 million compared to first quarter 2023.Total revenues were $143.6 million. Total revenues excluding ...